The Role of miR-101 in Esophageal and Gastric Cancer

References

• Wang CZ , DengF , LiHet al. MiR-101: a potential therapeutic target of cancers. Am. J. Transl. Res.10(11), 3310–3321 (2018).
   PubMed Web of Science ®Google Scholar
• Hu J , WuC , ZhaoX , LiuC. The prognostic value of decreased miR-101 in various cancers: a meta-analysis of 12 studies. Onco. Targets Ther.10, 3709–3718 (2017).
   PubMed Web of Science ®Google Scholar
• Chandra Mangalhara K , ManvatiSet al. ERK2-ZEB1-miR-101-1 axis contributes to epithelial-mesenchymal transition and cell migration in cancer. Cancer Lett.391, 59–73 (2017).
   PubMed Web of Science ®Google Scholar
• Canu V , SacconiA , LorenzonLet al. MiR-204 down-regulation elicited perturbation of a gene target signature common to human cholangiocarcinoma and gastric cancer. Oncotarget8(18), 29540–29557 (2017).
   PubMedGoogle Scholar
• Sacconi A , BiagioniF , CanuVet al. miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer. Cell Death Dis.3(11), e423 (2012).
   PubMedGoogle Scholar
• Lorenzon L , CippitelliC , AvantifioriRet al. Down-regulated miRs specifically correlate with non-cardial gastric cancers and Lauren’s classification system. J. Surg. Oncol.116(2), 184–194 (2017).
   PubMed Web of Science ®Google Scholar
• Zhou Z , XuH , DuanY , LiuB. MicroRNA-101 suppresses colorectal cancer progression by negative regulation of Rap1b. Oncol. Lett.20(3), 2225–2231 (2020).
   PubMed Web of Science ®Google Scholar
• Varambally S , CaoQ , ManiRSet al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science322(5908), 1695–1699 (2008).
   PubMed Web of Science ®Google Scholar
• Huang SD , YuanY , ZhuangCWet al. MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma. Mol. Cancer11, 51 (2012).
   PubMed Web of Science ®Google Scholar
• Lin C , HuangF , LiQZ , ZhangYJ. miR-101 suppresses tumor proliferation and migration, and induces apoptosis by targeting EZH2 in esophageal cancer cells. Int. J. Clin. Exp. Pathol.7(10), 6543–6550 (2014).
   PubMed Web of Science ®Google Scholar
• Qiu BQ , LinXH , YeXDet al. Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101/EZH2 axis as a ceRNA. Aging12(2), 1843–1856 (2020).
   PubMedGoogle Scholar
• Wu X , DinglinX , WangXet al. Long noncoding RNA XIST promotes malignancies of esophageal squamous cell carcinoma via regulation of miR-101/EZH2. Oncotarget8(44), 76015–76028 (2017).
   PubMedGoogle Scholar
• Wang X , LiM , WangZet al. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells. J. Biol. Chem.290(7), 3925–3935 (2015).
   PubMed Web of Science ®Google Scholar
• Farooqi AA , LegakiE , GazouliM , RinaldiS , BerardiR. MALAT1 as a versatile regulator of cancer: overview of the updates from predatory role as competitive endogenous RNA to mechanistic in-sights. Curr. Cancer Drug Targets doi:10.2174/1568009620999200730183110 (2020) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Syllaios A , MorisD , KarachaliouGSet al. Pathways and role of MALAT1 in esophageal and gastric cancer. Oncol. Lett.21(5), 343 (2021).
   PubMed Web of Science ®Google Scholar
• Li RQ , RenY , LiuW , PanW , XuFJ , YangM. MicroRNA-mediated silence of onco-lncRNA MALAT1 in different ESCC cells via ligand-functionalized hydroxyl-rich nanovectors. Nanoscale9(7), 2521–2530 (2017).
   PubMed Web of Science ®Google Scholar
• Chen M , LiuP , ChenYet al. Long noncoding RNA FAM201A mediates the radiosensitivity of esophageal squamous cell cancer by regulating ATM and mTOR expression via miR-101. Front. Genet.9, 611 (2018).
   PubMed Web of Science ®Google Scholar
• Shao Y , LiP , ZhuSTet al. Cyclooxygenase-2, a potential therapeutic target, is regulated by miR-101 in esophageal squamous cell carcinoma. PLoS ONE10(11), e0140642 (2015).
   PubMed Web of Science ®Google Scholar
• Haiart S , WatsonDI , LeongMP , AstillD , BrightT , HusseyDJ. MicroRNA-196a & microRNA-101 expression in Barrett’s oesophagus in patients with medically and surgically treated gastro-oesophageal reflux. BMC Res. Notes4, 41 (2011).
   PubMedGoogle Scholar
• Wang HJ , RuanHJ , HeXJet al. MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion. Eur. J. Cancer46(12), 2295–2303 (2010).
   PubMed Web of Science ®Google Scholar
• Carvalho J , van GriekenNC , PereiraPMet al. Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. J. Pathol.228(1), 31–44 (2012).
   PubMed Web of Science ®Google Scholar
• Rossi T , TedaldiG , PetracciEet al. E-cadherin downregulation and microRNAs in sporadic intestinal-type gastric cancer. Int. J. Mol. Sci.20(18), 4452 (2019).
   PubMed Web of Science ®Google Scholar
• He XP , ShaoY , LiXLet al. Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth. FEBS J.279(22), 4201–4212 (2012).
   PubMed Web of Science ®Google Scholar
• Imamura T , KomatsuS , IchikawaDet al. Low plasma levels of miR-101 are associated with tumor progression in gastric cancer. Oncotarget8(63), 106538–106550 (2017).
   PubMedGoogle Scholar
• Bao J , XuY , WangQet al. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2. Biomed. Pharmacother.92, 1030–1037 (2017).
   PubMed Web of Science ®Google Scholar
• Wang L , ShenJ , JiangY. Circ_0027599/PHDLA1 suppresses gastric cancer progression by sponging miR-101-3p.1. Cell Biosci.8, 58 (2018).
   PubMed Web of Science ®Google Scholar
• Dong XQ , ZhangYH , ShangXQ , ZengYJ. Effects of miR-101 on the proliferation and apoptosis of gastric mucosal epithelial cells via Nrf2/ARE signaling pathway. Eur. Rev. Med. Pharmacol. Sci.23(12), 5187–5194 (2019).
   PubMed Web of Science ®Google Scholar
• Chen DL , JuHQ , LuYXet al. Long non-coding RNA XIST regulates gastric cancer progression by acting as a molecular sponge of miR-101 to modulate EZH2 expression. J. Exp. Clin. Cancer Res.35(1), 142 (2016).
   PubMedGoogle Scholar
• Yao L , YanJ , GanL , HuangS , ChengF , FangN. Upregulation of MANCR predicts poor survival in patients with gastric cancer. Oncol. Lett.18(6), 6801–6806 (2019).
   PubMed Web of Science ®Google Scholar
• Liu HT , XingAY , ChenXet al. MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers. Oncotarget6(35), 37458–37470 (2015).
   PubMedGoogle Scholar
• Tsai KW , HuLY , ChenTWet al. Emerging role of microRNAs in modulating endothelin-1 expression in gastric cancer. Oncol. Rep.33(1), 485–493 (2015).
   PubMed Web of Science ®Google Scholar
• Zhou X , XiaY , LiL , ZhangG. MiR-101 inhibits cell growth and tumorigenesis of Helicobacter pylori related gastric cancer by repression of SOCS2. Cancer Biol. Ther.16(1), 160–169 (2015).
   PubMed Web of Science ®Google Scholar
• Dong X , LiuY. Expression and significance of miR-24 and miR-101 in patients with advanced gastric cancer. Oncol. Lett.16(5), 5769–5774 (2018).
   PubMed Web of Science ®Google Scholar
• Li G , YangF , GuS , LiZ , XueM. MicroRNA-101 induces apoptosis in cisplatin-resistant gastric cancer cells by targeting VEGF-C. Mol. Med. Rep.13(1), 572–578 (2016).
   PubMed Web of Science ®Google Scholar